[oai_citation:6PubMed]( [oai_citation:7PMC]( 5) Gastroprotective/cytoprotective actions in rodent models Multiple rat studies describe protection/healing in NSAID-induced and other gastric ulcer paradigms, consistent with mucosal cytoprotection concepts
While not a treatment for medical conditions, research suggests these peptides may support: Growth hormone deficiency Age-related decline in lean body mass Metabolic resistance or stubborn abdominal fat Slowed recovery from exercise or injury Use should always be part of a guided wellness or hormone optimization program
The mechanisms are different and do not directly conflict, but absence of conflict is not the same as evidence of benefit
Blood pressure regulation by the angiotensin type 1 receptor in the proximal tubule
It can also reduce muscarinic signs and symptoms, such as salivation, bronchospasm, etc., but this action is relatively unimportant since atropine is adequate for this purpose, and atropine is typically given first before pralidoxime